Nautilus Biotechnology, Inc.

NASDAQ:NAUT

Biotechnology

Healthcare
$2.43 +2.06%

+$0.05 today

Market cap
$309.51M
Beta
0.75
P/E (TTM)
-4.9
EPS (TTM)
-$0.45
52W Low $0.62High $4.31

Volume 4.55M

Average 0.40M

NAUT Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

No reported Operating Margin figures are available to summarize.

Operating Margin history

Percent of revenue · from the income statement

No Operating Margin data reported for this period type.

Operating Margin vs competitors

How NAUT compares with its peers on the latest reported figures

NAUT Competitors Peer median
Operating Margin for NAUT and competitors
Company Period LTM level YoY 3-year change
ASMBAssembly Biosciences, Inc.LTM Mar 2026-19.1% +119.8 pp—
ENTAEnanta Pharmaceuticals, Inc.LTM Mar 2026-87.2% +71.2 pp+13.1 pp
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026-196.7% -136.0 pp-117.4 pp
FHTXFoghorn Therapeutics Inc.LTM Mar 2026-286.2% +128.2 pp+343.6 pp
PYXSPyxis Oncology, Inc.LTM Mar 2026-619.6% ——
HUMAHumacyte, Inc.LTM Mar 2026-5649.2% -4216.0 pp+132.7 pp
TNYATenaya Therapeutics, Inc.LTM Mar 2026-38159.1% ——
NAUTNautilus Biotechnology, Inc.FY2025— ——
SGMTSagimet Biosciences Inc.FY2025— ——
IMRXImmuneering CorporationFY2025— ——
ZURAZura Bio LimitedFY2025— ——
Peer median (excluding NAUT) -286.2%+71.2 pp+72.9 pp

Competitors are the stored peer set for NAUT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue2.84M3.42M5.71M6.35M6.47M
Gross Profit(2.84M)(3.42M)(5.71M)(6.35M)(6.47M)
Gross Margin—————
Research & Development26.51M36.46M47.25M50.48M41.11M
Selling, General & Admin21.15M23.75M28.9M31M25.73M
Operating Expenses47.66M60.2M70.45M75.12M60.37M
Depreciation & Amortization2.84M3.42M1.85M6.35M6.47M
EBITDA(47.47M)(54.51M)(61.83M)(64.43M)(52.54M)
EBITDA Margin—————
Operating Income(50.5M)(63.62M)(76.15M)(81.48M)(66.84M)
Operating Margin—————
Interest Income329K5.82M12.55M10.78M7.87M
Interest Expense05.82M000
Other Income / Expenses183K5.69M12.48M10.7M7.84M
Income Before Tax(50.32M)(57.92M)(63.68M)(70.78M)(59M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(50.32M)(57.92M)(63.68M)(70.78M)(59M)
Net Margin—————
EPS (Basic)(0.60)(0.46)(0.51)(0.56)(0.47)
EPS (Diluted)(0.60)(0.46)(0.51)(0.56)(0.47)
Weighted Avg Shares84.46M124.59M124.92M125.43M126.26M
Weighted Avg Shares (Diluted)84.46M124.59M124.92M125.43M126.26M

Nautilus Biotechnology, Inc.

NASDAQ:NAUT

Intrinsic Alpha fair value

Locked

Current Price

$2.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.